rupatadine has been researched along with Chronic Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, H; Hide, M; Suzuki, T; Tanaka, A | 1 |
| Dakhale, GN; Hiware, SK; Mahatme, MS; Mishra, DB; Mukhi, JI; Salve, AM; Shinde, AT | 1 |
| Badyal, DK; Johnson, M; Kwatra, G; Thomas, EA | 1 |
| Abajian, M; Church, MK; Curto-Barredo, L; Giménez-Arnau, A; Izquierdo, I; Krause, K; Maurer, M; Santamaria, E | 1 |
| Barkai, L; Izquierdo, I; Maurer, M; Mezei, G; Mitha, E; Potter, P; Santamaría, E | 1 |
| Armentia, A; Dueñas-Laita, A; Martín-Armentia, B; Pinacho, F; Ruiz-Muñoz, P | 1 |
| Cassano, N; Delle Donne, P; Di Leo, E; Foti, C; Nettis, E; Vacca, A; Vena, GA | 1 |
| Giménez-Arnau, A; Izquierdo, I; Maurer, M | 1 |
| Maurer, M; Metz, M | 1 |
| Ahmed, I; Goud, P; Jaida, J; Maiti, R; Palani, A; Raghavendra, BN | 1 |
| Arnaiz, E; Donado, E; Gimenez-Arnau, A; Ianosi, S; Izquierdo, I; Kaszuba, A; Malbran, A; Perez, I; Poop, G; Pujol, RM | 1 |
| Bachert, C; Bousquet, J; Canonica, WG; Gimenez-Arnau, A; Kowalski, ML; Martí-Guadaño, E; Maurer, M; Mullol, J; Picado, C; Scadding, G; Van Cauwenberge, P | 1 |
2 review(s) available for rupatadine and Chronic Disease
| Article | Year |
|---|---|
Rupatadine for the treatment of allergic rhinitis and urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Cyproheptadine; Histamine H1 Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2011 |
Rupatadine in allergic rhinitis and chronic urticaria.
Topics: Adolescent; Animals; Anti-Allergic Agents; Child; Chronic Disease; Clinical Trials as Topic; Cyproheptadine; Dogs; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2008 |
9 trial(s) available for rupatadine and Chronic Disease
| Article | Year |
|---|---|
Efficacy and safety of rupatadine in Japanese adult and adolescent patients with chronic spontaneous urticaria: A double-blind, randomized, multicenter, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Anti-Allergic Agents; Asian People; Child; Chronic Disease; Cyproheptadine; Double-Blind Method; Humans; Middle Aged; Treatment Outcome; Urticaria; Young Adult | 2019 |
Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
Topics: Adult; Cetirizine; Chronic Disease; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Prospective Studies; Urticaria | 2014 |
Levocetirizine and rupatadine in chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Cetirizine; Child; Chronic Disease; Cyproheptadine; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Platelet Activating Factor; Quality of Life; Severity of Illness Index; Tumor Necrosis Factor-alpha; Urticaria; Young Adult | 2015 |
Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria.
Topics: Adult; Aged; Chronic Disease; Cold Temperature; Cross-Over Studies; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Remission Induction; Spain; Time Factors; Treatment Outcome; Urticaria; Young Adult | 2016 |
Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Topics: Age Factors; Child; Child, Preschool; Chronic Disease; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hungary; Loratadine; Male; Quality of Life; Remission Induction; South Africa; Time Factors; Treatment Outcome; Urticaria | 2016 |
Successful treatment of chronic drug-resistant urticaria with alprazolam.
Topics: Alprazolam; Chronic Disease; Cyproheptadine; Humans; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Recurrence; Treatment Outcome; Urticaria | 2009 |
The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
Topics: Adult; Chronic Disease; Cyproheptadine; Dose-Response Relationship, Drug; Female; Health Surveys; Histamine H1 Antagonists, Non-Sedating; Humans; Logistic Models; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Urticaria | 2009 |
Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety.
Topics: Adolescent; Adult; Cetirizine; Child; Chronic Disease; Cyproheptadine; Female; Follow-Up Studies; Histamine Antagonists; Humans; Male; Middle Aged; Single-Blind Method; Treatment Outcome; Urticaria; Young Adult | 2011 |
Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Cyproheptadine; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome; Urticaria | 2007 |
1 other study(ies) available for rupatadine and Chronic Disease
| Article | Year |
|---|---|
Treatment of acquired cold urticaria with rupatadine.
Topics: Adult; Chronic Disease; Cold Temperature; Cyproheptadine; Female; Humans; Middle Aged; Platelet Activating Factor; Treatment Outcome; Urticaria | 2009 |